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To clarify the role of bats in the ecology of Ebola viruses, 
we assessed the prevalence of Ebola virus antibodies in 
a large-scale sample of bats collected during 2015–2017 
from countries in Africa that have had previous Ebola out-
breaks (Guinea, the Democratic Republic of the Congo) or 
are at high risk for outbreaks (Cameroon). We analyzed 
4,022 blood samples of bats from >12 frugivorous and 
27 insectivorous species; 2–37 (0.05%–0.92%) bats were 
seropositive for Zaire and 0–30 (0%–0.75%) bats for Sudan 
Ebola viruses. We observed Ebola virus antibodies in 1 in-
sectivorous bat genus and 6 frugivorous bat species. Cer-
tain bat species widespread across Africa had serologic evi-
dence of Zaire and Sudan Ebola viruses. No viral RNA was 
detected in the subset of samples tested (n = 665). Ongoing 
surveillance of bats and other potential animal reservoirs 
are required to predict and prepare for future outbreaks.
Since the first outbreak of Ebola virus disease (EVD) in 1976 in the northern part of the Democratic Republic of 
the Congo (DRC), 26 recognized outbreaks have occurred 
in humans across Africa; fatality rates of outbreaks have 
been 25%–90% (1–4). Each EVD outbreak most likely re-
sulted from independent zoonotic events.
Bats are believed to play a role in the ecology of Eb-
ola viruses as a reservoir species (5). Bats might infect 
humans directly or via intermediate amplifying hosts, like 
nonhuman primates or duikers (6,7). Bats might serve as a 
source of infection in certain areas where bats are hunted 
and eaten as bushmeat, but infection could also occur af-
ter consumption of fruits contaminated with saliva, urine, 
or feces from Ebola virus–infected bats (8,9). Ebola virus 
emergence through exposure to bats was suspected for at 
least 2 outbreaks: Luebo (the DRC) in 2007 and West Af-
rica in 2013 (10,11).
Relatively few data are available to support the role 
of bats in the ecology of Ebola viruses. During the EVD 
outbreaks of 2003 in Gabon and the Congo, Zaire Ebola 
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Ebola Virus in Frugivorous and Insectivorous Bats
virus RNA and antibodies were detected in live-caught 
specimens from 3 fruit bat species (Epomops franqueti, 
Hypsignathus monstrosus, Myonycteris torquata); virus 
sequences were found in the livers or spleens of a few bats 
(6). In subsequent studies in Gabon, the Congo, Ghana, and 
Zambia, antibodies were detected in additional frugivorous 
bat species (Eidolon helvum, Epomophorus gambianus, 
Rousettus aegyptiacus, Micropteropus pusillus) and 1 in-
sectivorous species (Mops condylurus) (12–16). The am-
plification and sequencing of viral RNA of other filoviruses 
in bats, such as Marburg virus in bats from Africa (17–20), 
Lloviu virus in bats from Europe (21), and new filoviruses 
in bats from China (22), has provided additional evidence 
for a possible role of bats in Ebola virus ecology.
In general, EVD outbreaks have been limited in terms 
of their geographic spread and chains of human-to-human 
transmission (1). However, during the 2013–2016 out-
break, virus spread to the urban areas of 3 countries, infect-
ing ≈30,000 persons in Guinea, Sierra Leone, and Liberia, 
and ≈11,000 deaths were recorded (23). This outbreak il-
lustrated the potential for epidemic spread from a single 
zoonotic transmission, with severe public health and so-
cioeconomic impact (24). Additional studies are urgently 
needed to identify the animal reservoir, predict EVD out-
break risks, and improve our capacity to control epidemics.
In previous modeling studies, areas were defined as at 
risk for EVD outbreaks on the basis of data collected from 
a limited number of wildlife bat species from a few geo-
graphic regions (5,25). Also, a wide variety of serologic 
assays and interpretation criteria have been used, making 
comparison of results challenging (12–16,26,27). For this 
study, we performed a large serosurvey with a highly spe-
cific and sensitive high-throughput assay to assess Ebola 
virus prevalence in bats from Africa (28). We studied bats 
from Guinea and the DRC, countries with previous EVD 
outbreaks, and Cameroon, a country considered at high risk 
for future EVD outbreaks (5,25).
Materials and Methods
Study Sites and Sample Collection
During November 2015–August 2017, we collected sam-
ples from free-ranging frugivorous and insectivorous bats 
in Guinea, Cameroon, and the DRC. We captured bats at 
night using ground mist nets or harp traps in roosting and 
foraging sites. We set up ground mist nets (12 × 3.2 m) 
of 30-mm and 60-mm mesh sizes at different heights (1–7 
m) to maximize capture of different species. We opened 
nets or harp traps just before sunset and checked for bats 
every 1–2 hours. Captured bats were released the same 
night immediately after sampling. Using bat whole blood 
taken by venipuncture of the propatagial or brachial vein, 
we dropped blood samples directly onto Whatman 903 
filter paper (GE Healthcare, Feasterville-Trevose, PA, 
USA). We air-dried and preserved samples individually in 
plastic bags containing silica desiccant and stored them in 
hermetic boxes; 2–3 weeks later, we transferred dried blood 
spots to -20°C until needed for analysis. Data recorded in 
the field included information on capture site (global posi-
tioning system coordinates, ecologic environment), capture 
method, morphology (body measurements, weight, color), 
sex, age class (adult, juvenile), and species (identified visu-
ally). We collected negative control samples (n = 145) from 
a captive-born insectivorous bat species (103 Carollia per-
spicillata bats) hosted at the Parc Zoologique de Montpel-
lier (Montpellier, France) and 2 frugivorous bat species (19 
Pteropus giganteus bats, 23 R. aegyptiacus bats) hosted at 
Wilhelma Zoo and Botanical Garden (Stuttgart, Germany). 
We collected and preserved samples the same way we did 
for free-ranging bats.
Screening for Ebola Virus Antibodies
We tested dried blood spots with a Luminex-based sero-
logic assay adapted for bats (28) (online Technical Appen-
dix, https://wwwnc.cdc.gov/EID/article/24/12/18-0740-
Techapp1.pdf). The assay included recombinant Ebola 
virus proteins glycoprotein, nucleoprotein, or viral protein 
40 for different lineages: Zaire, Sudan, Bundibugyo, and 
Reston. We reconstituted plasma from dried blood spots as 
previously described (28) and incubated 100 μL of sample 
(final plasma dilution 1:2,000) with 50 µL of recombinant 
protein–coated beads (2 µg protein/1.25 × 106 beads) in 
96-well flat-bottom filter plates (Millipore, Tullagreen, 
Ireland) on a plate shaker at 300 rpm for 16 h at 4°C in 
the dark. After washing, we added 0.1 μg/mL of goat anti-
bat biotin–labeled IgG (Euromedex, Souffelweyersheim, 
France) per well and incubated for 30 min at 300 rpm. Af-
ter another round of washing, we added 50 µL of 4 µg/mL 
streptavidin-R-phycoerythrin (Fisher Scientific, Illkirch, 
France) per well and incubated for 10 min at 300 rpm. Re-
actions were read with BioPlex-200 (BioRad, Marnes-la-
Coquette, France). We expressed results as median fluo-
rescence intensity (MFI) per 100 beads. We included 3 
samples on every plate to validate interassay repeatability.
Determination of Cutoffs
In the absence of positive control samples, we used 4 dif-
ferent statistical methods to determine the MFI cutoff value 
for each antigen (29,30) (online Technical Appendix Table 
1). First, we used a general formula that involved the MFI 
of the 145 negative control samples, and we assigned the 
cutoff as mean plus 4 times the SD (mean + 4×SD). Second, 
we used a change point analysis (31) to identify the value 
at which statistical properties of the underlying probability 
distribution changed. This value was used to identify outli-
ers and classify them as reactive. We used the R package 
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changepoint (32) to calculate a single shift in the arithmetic 
mean with the at-most-1-change method (33). Third, we 
fitted univariate distributions to our data and defined the 
cutoff as a 0.001 risk for error, as was used in other virus 
serology studies (13,34). We reduced the set of candidate 
distributions following a bootstrapped skewness-kurtosis 
analysis (35). We performed fitting by maximum-likeli-
hood estimation and selected the best-fit distribution on the 
basis of the Akaike information criteria with the R library 
fitdistrplus (36). A negative binomial distribution best-fit 
the data; however, we also used the negative exponential 
distribution as in Pourrut et al. and Laing et al. (13,34). For 
every antigen, we computed bootstrap values using 10,000 
replicates and averaged. We performed analyses with R 
version 3.3.2 software (https://www.r-project.org/). We 
considered a blood sample reactive if the MFI of the reac-
tion was above the cutoff. We defined Ebola virus antibody 
positivity as reactivity to glycoprotein and nucleoprotein of 
the same lineage, as was done in our previous study (28).
Nucleic Acid Extraction and PCR Screening for  
Ebola Virus RNA
We extracted total DNA and RNA from dried blood spots as 
previously described using Nuclisens (bioMerieux, Marcy-
l’Etoile, France) or m2000sp methods (Abbott Molecular 
Inc., Des Plaines, IL, USA), which are known for a high per-
formance recovering nucleic acids from dried blood spots 
(37,38). For bat species from Cameroon and Guinea, we 
screened for Zaire Ebola virus RNA by seminested reverse 
transcription PCR (RT-PCR) targeting the nucleoprotein 
region of the virus genome. We amplified a 126-bp frag-
ment of Zaire Ebola virus using primers NP1F1 (forward, 
5′-CGGACACACAAAAAGAAWGAA-3′) and NP1R-ZR 
(reverse, 5′-CTCTATCTTKGTGATRTGGCTCTGA-3′) 
in the first round of PCR and NP1F2 (forward, 5′- TTGT-
GTGCGARTAACTAYGAGGAAG-3′) plus NP1R-ZR 
in the second round. For species from the DRC, we per-
formed seminested RT-PCR targeting the viral protein 35 
region of the genome using the protocol of He et al. with 
modifications (41). In the first round, we amplified a 217-
bp fragment with primers VP35-F (5′-ATYATGTATGAT-
CACYTVCCWGG-3′) and VP35-R (52-AGCGRATGTG-
GATSACRGGT-32) and, in the second round, a 184-bp 
product with primers VP35-R and VP35-in-F (5′-GCTT-
TYCAYCAAYTAGTRCAAG-3′).
Molecular Confirmation of Bat Species
We confirmed bat species identification recorded in the field 
on a subset of samples by using molecular tests. We am-
plified an ≈800-bp fragment of mitochondrial cytochrome 
b using primers cytb-L14724 (forward) and cytb-H15506 
(reverse) (11,39,40). We substituted the cytb-L14724 
primer with cytb-L140217 (5′-ATGACCAACATCC-
GAAAATCNCAC-3′) to improve PCR performance for 
certain species. We purified PCR products through agarose 
gel (1%) and directly sequenced on an ABI 3500 sequencer 
(Applied Biosystems, Courtaboeuf, France). We performed 
BLAST analyses (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to 
identify the most similar bat species. For samples with no or 
low similarity (<97%) hits with species in GenBank, we per-
formed phylogenetic analyses with newly obtained sequenc-
es and reference sequences for different bat species using 
maximum-likelihood methods implemented with PhyML 
(http://www.atgc-montpellier.fr/phyml/) to determine genus.
Results
Bat Species and Sampling
We analyzed blood samples from 4,022 wild bats from 21 
different regions in Cameroon (n = 10), Guinea (n = 8), and 
the DRC (n = 3) (Figure 1; Table 1). To increase species 
diversity, we captured bats in multiple ecologic settings: for-
ests (49%), open fields (10%), villages (29%), plantations 
(7%), and urban areas (5%). For 1,470 (36.5%) samples, 
species identification in the field was confirmed by sequence 
analysis. At each site, >1 sample was confirmed per sampling 
date, capture method, and morphologic description. For the 
remaining samples, species identification was extrapolated 
by combining molecular and morphologic data, including 
photographs whenever available. For some insectivorous bat 
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Table 1. Bat samples collected for Ebola virus serology by study 
site, Guinea, Cameroon, and the Democratic Republic of the 
Congo, 2015–2017 
Country, site No. samples 
Democratic Republic of the Congo  
 Boma 156 
 Kimpese 202 
 Zongo 472 
Subtotal  830 
Cameroon  
 Yaoundé 126 
 Libellengoi Sud 44 
 Mbalmayo 48 
 Bipindi 479 
 Campo M’an 344 
 North Dja 295 
 Ekom 122 
 Djoum 56 
 Mambele 348 
 Mbam Djerem 156 
Subtotal 2,018 
Guinea  
 Conakry 107 
 Kindia 323 
 Kankan 378 
 Koundara 90 
 Mamou 147 
 Gueckedou 49 
 Macenta 9 
 Nzerekore 71 
Subtotal 1,174 
Total 4,022 
 
Ebola Virus in Frugivorous and Insectivorous Bats
families (Miniopteridae, Molossidae, Nycteridae, Rhinolo-
phidae), identification was possible only at the genus level; 
for some Molossidae bats, we could not distinguish between 
Mops and Chaerephon genera because of the lack of se-
quences in GenBank (Table 2). For 87 (2.16%) samples, spe-
cies identification was not possible because incomplete data 
were recorded in the field, and available biologic materials 
were insufficient for molecular confirmation. We collected 
samples from 1,736 (43.2%) frugivorous bats (family Ptero-
podidae) of 12 species and 2,199 (54.7%) insectivorous bats 
(7 families) of >27 species. The insectivorous bat families 
sampled, in order of decreasing frequency, were Hipposid-
eridae (31.9%), Molossidae (13.4%), Miniopteridae (5.8%), 
Rhinolophidae (2.1%), Vespertilionidae (0.8%), Nycteridae 
(0.5%), and Emballonuridae (0.12%). Overall, 54.7% of 
bats were female and 43.8% were male; for 1.5% (n = 60) of 
bats, sex was unknown. Most (77.9%) bats were adults, and 
9.6% were juveniles; for 12.5% (n = 502) of bats, age could 
not be determined or was not recorded.
Bats Antibodies against Different Ebola Virus Antigens
We tested all samples for Ebola virus antibodies. The num-
ber of samples reacting with >1 antigen was 734 (18.2%) 
by the mean + 4×SD method, 274 (6.8%) for the change-
point method, 175 (4.4%) for the binomial method, and 457 
(11.4%) for the exponential method. Blood samples fre-
quently reacted with glycoprotein antigens; samples reacted 
most with Zaire and Sudan Ebola virus antigens and least 
with Reston (Table 3). Simultaneous reactivity to >1 anti-
gen (i.e., glycoprotein, nucleoprotein, viral protein 40) from 
the same virus lineage was rare. Simultaneous reactivity to 
the same antigen from different virus lineages was frequent; 
32.3%–76.7% of blood samples were reactive to glycopro-
tein from >2 Ebola virus species, 18.4%–34.0% to viral pro-
tein 40, and 1.5%–4.4% to nucleoprotein (online Technical 
Appendix Table 2). When using the criterion simultaneous 
presence of antibodies to nucleoprotein and glycoprotein, the 
antibody positivity for Zaire or Sudan Ebola virus antibodies 
was generally <1% for all bats tested, regardless of cutoff 
method, and was lower among insectivorous than frugivo-
rous bats: 0.05%–0.27% (insectivorous) and 0.06%–1.79% 
(frugivorous) for Zaire Ebola virus versus 0%–0.09% (in-
sectivorous) and 0%–1.61% (frugivorous) for Sudan Ebola 
virus (Table 3; Figure 2). Three samples were positive for 
Zaire and Sudan Ebola viruses, but only by less stringent cut-
off methods (i.e., mean + 4×SD).
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Figure 1. Study sites for bat 
blood sample collection for 
Ebola virus serology, Guinea, 
Cameroon, and the Democratic 
Republic of the Congo, 2015–
2017. Yellow dots indicate 
sampling sites for bats in our 
study, and green dots indicate 
sampling sites in previously 
published studies. Dark red 
shading indicates highest and 
light yellow lowest risk for Ebola 
virus spillover events. Study sites 
are numbered: 1, Koundara; 2, 
Conakry; 3, Kindia; 4, Mamou; 
5, Kankan; 6, Gueckedou; 7, 
Macenta; 8, Nzerekore; 9, Mbam 
Djerem; 10, Libellengoi Sud; 11, 
Yaoundé; 12, Ekom; 13, North 
Dja; 14, Bipindi; 15, Mbalmayo; 
16, Djoum; 17, Mambele; 18, 
Campo M’an; 19, Boma; 20, 
Kimpese; 21, Zongo. Countries 
with reported index Ebola cases 
and countries without such  
cases but deemed at risk are 
indicated. Map of Africa  
adapted from Pigott et al. (5) 
(https://creativecommons.org/
licenses/by/4.0/) by adding 
locations of collection sites.
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Zaire and Sudan Ebola Virus Reactivity of Different  
Bat Species
We estimated specific reactivity to Zaire and Sudan Ebo-
la viruses by bat species. We did not include Bundibugyo 
and Reston because recombinant nucleoproteins were 
not available. Among insectivorous bats, only blood 
samples from Mops sp. bats (1–6/494) were positive for 
Zaire or Sudan Ebola virus antibodies (Table 4). Among 
frugivorous bats, samples from E. helvum, H. monstro-
sus, and R. aegyptiacus bats had the highest reactivity. 
We observed Zaire and Sudan Ebola virus seropositivity 
in these 3 species with almost all cutoff methods: 0.2%–
3.3% for Zaire Ebola virus and 1.0%–2.9% for Sudan 
Ebola virus in E. helvum bat samples, 0.5%–1.6% for 
Zaire Ebola virus and 1.1%–4.3% for Sudan Ebola virus 
in H. monstrosus bat samples, and 0.6%–2.5% for Zaire 
Ebola virus and 0.8%–1.4% for Sudan Ebola virus in R. 
aegyptiacus bat samples. We observed 2.4% Zaire Ebola 
virus–seropositive samples for Lissonycteris angolensis 
bats and 0.5% for Epomophorus sp. bats, but only by less 
stringent cutoff methods. One sample from M. pusillus 
bats was seropositive for Sudan Ebola virus. No samples 
from E. franqueti or M. torquata bats were reactive with 
any Ebola virus antigens. Samples from the 1 Scotonyc-
teris zenkeri bat and 20 Megaloglossus woermanni bats 
were seronegative. Overall, Zaire or Sudan Ebola virus 
antibodies were observed in 7 (1 insectivorous and 6 fru-
givorous) bat species.
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Table 2. Bat species sampled for Ebola virus serology, Guinea, Cameroon, and the DRC, 2015–2017* 
Family Species DRC, no. Cameroon, no. Guinea, no. Total, no. 
Emballonuridae Coleura afra 0 5 0 5 
Hipposideridae Hipposideros abae 0 0 37 37 
 H. beatus 0 4 0 4 
 H. cyclops 0 14 0 14 
 H. fuliginosus 0 2 0 2 
 H. gigas 2 9 2 13 
 H. jonesi 0 1 12 13 
 H. ruber/caffer 127 807 237 1,171 
 Hipposideros sp. 28 0 0 28 
Subtotal  157 837 288 1,282 
Miniopteridae Miniopterus sp. 205 0 27 232 
Molossidae Chaerephon sp. 0 0 44 44 
 Mops condylurus 0 0 110 110 
 Mops sp. 0 256 0 256 
 Mops/Chaerephon sp. 0 8 120 128 
Subtotal   0 264 274 538 
Nycteridae  Nycteris sp. 0 7 15 22 
Rhinolophidae Rhinolophus alcyone 0 16 0 16 
 R. darlingii 3 0 0 3 
 R. fumigatus 0 0 19 19 
 R. landeri 0 0 6 6 
 Rhinolophus sp. 3 38 1 42 
Subtotal  6 54 26 86 
Vespertilionidae Glauconycteris variegata 0 3 0 3 
 Kerivoula sp. 0 1 0 1 
 Myotis bocagii 0 3 0 3 
 Neoromicia sp. 0 5 0 5 
 Scotophilus leucogaster 0 0 15 15 
 S. nigrita 0 0 1 1 
 S. nux 0 6 0 6 
Subtotal   0 18 16 34 
Pteropodidae Eidolon helvum 305 158 17 480 
 Epomophorus gambianus 0 0 191 191 
 Epomophorus wahlbergi 0 16 0 16 
 Epomops buettikoferi 0 0 4 4 
 Epomops franqueti 20 256 0 276 
 Hypsignathus monstrosus 1 176 8 185 
 Lissonycteris angolensis 22 30 32 84 
 Megaloglossus woermanni 1 19 0 20 
 Micropteropus pusillus 44 2 18 64 
 Myonycteris torquata 35 21 0 56 
 Rousettus aegyptiacus 0 131 228 359 
 Scotonycteris zenkeri 0 1 0 1 
Subtotal  428 810 498 1,736 
Inderminate species  34 23 30 87 
Total  830 2,018 1,174 4,022 
*DRC, the Democratic Republic of the Congo. 
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Comparison of Zaire Ebola Virus Seroprevalence in 
Bats from Africa across Studies
For comparison, we compiled data regarding Zaire Ebola 
virus serology in bats of known species from previous stud-
ies (n = 4,493) and this study (n = 3,935; 46.7%) (Tables 5, 
6). Data were available for 3,023 insectivorous bats of ≈30 
species from 7 different families; 2,199 (72.7%) were from 
this study (Table 5). Insectivorous bat samples originated 
from Guinea, Cameroon, the DRC, and Gabon. Zaire Ebola 
virus reactivity has been observed only in M. condylurus 
bat samples from Gabon and Mops sp. bat samples from 
Cameroon. Data were available for 5,405 frugivorous bats 
of 17 species from 12 genera from West (Guinea, Ghana), 
West Central (Cameroon, Gabon, the Congo, the DRC), 
and East (Zambia) Africa (Table 6). No Zaire Ebola virus 
reactivity has been seen in blood samples from bat species 
Casinycteris, Megaloglossus, Nanonycteris, and Scotonyc-
teris, but only a limited number of samples (n = 152) have 
been tested. Overall, blood samples from 8 frugivorous bat 
species have been found reactive with Zaire Ebola virus an-
tigens. Blood samples from E. helvum, H. monstrosus, and 
R. aegyptiacus bats from several countries across Africa 
have been reported to be seropositive. Reactivity has been 
observed with samples from E. gambianus bats in Ghana 
(10.8%) and Guinea. Reactivity was observed with large 
sample sets from E. franqueti bats derived from Gabon 
and the Congo and a small sample set from Ghana but not 
Guinea, Cameroon, or the DRC. M. pusillus and M. torqua-
ta bats tested positive for Zaire Ebola virus antibodies in 
studies in which large sample sets were collected. Among 
L. angolensis bat samples, only those from Cameroon have 
tested positive for antibodies.
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Table 3. Blood samples from bats reactive with Ebola virus antigens in Luminex assay, by antigen, bat type, and statistical method 
used to determine cutoff, Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017* 
Ebola virus species, antigen Bat type 
Statistical method, no. (%) Estimated 
range, % Mean + 4SD Change point Binomial Exponential 
Zaire       
 NP Frugivorous 57 (3.28) 8 (0.46) 24 (1.38) 51 (2.94) 0.46–3.28 
 NP Insectivorous 15 (0.68) 1 (0.05) 6 (0.27) 15 (0.68) 0.05–0.68 
 NP Total 72 (1.79) 9 (0.22) 30 (0.75) 66 (1.64) 0.23–1.79 
 GP-K Frugivorous 365 (21.03) 141 (8.12) 20 (1.15) 113 (6.51) 1.15–21.03 
 GP-K Insectivorous 73 (3.32) 18 (0.82) 2 (0.09) 12 (0.55) 0.09–3.32 
 GP-K Total 440 (10.94) 160 (3.98) 22 (0.55) 125 (3.11) 0.55–10.94 
 GP-M Frugivorous 226 (13.02) 128 (7.37) 16 (0.92) 103 (5.93) 0.92–13.02 
 GP-M Insectivorous 31 (1.41) 14 (0.64) 2 (0.09) 12 (0.55) 0.09–1.41 
 GP-M Total 259 (6.44) 143 (3.56) 18 (0.45) 115 (2.86) 0.45–6.44 
 VP Frugivorous 55 (3.17) 8 (0.46) 24 (1.38) 44 (2.53) 0.46–3.17 
 VP Insectivorous 19 (0.86) 5 (0.23) 6 (0.27) 14 (0.64) 0.23–0.86 
 VP Total 75 (1.86) 14 (0.35) 30 (0.75) 59 (1.47) 0.35–1.86 
 NP + GP Frugivorous 31 (1.79) 31 (1.79) 1 (0.06) 7 (0.40) 0.06–1.79 
 NP + GP Insectivorous 6 (0.27) 6 (0.27) 1 (0.05) 1 (0.05) 0.05–0.27 
 NP + GP Total 37 (0.92) 37 (0.92) 2 (0.05) 8 (0.20) 0.05–0.92 
Sudan       
 NP Frugivorous 71 (4.09) 15 (0.86) 34 (1.96) 77 (4.44) 0.86–4.44 
 NP Insectivorous 12 (0.55) 1 (0.05) 5 (0.23) 18 (0.82) 0.05–0.82 
 NP Total 84 (2.09) 17 (0.42) 39 (0.97) 96 (2.39) 0.42–2.39 
 GP Frugivorous 459 (26.44) 147 (8.47) 17 (0.98) 121 (6.97) 0.98–26.44 
 GP Insectivorous 49 (2.23) 6 (0.27) 1 (0.05) 1 (0.05) 0.05–2.23 
 GP Total 509 (12.66) 154 (3.83) 18 (0.45) 125 (3.11) 0.45–12.66 
 VP Frugivorous 102 (5.88) 20 (1.15) 28 (1.61) 61 (3.51) 1.15–5.88 
 VP Insectivorous 19 (0.86) 4 (0.18) 6 (0.27) 18 (0.82) 0.18–0.86 
 VP Total 121 (3.01) 24 (0.60) 34 (0.85) 80 (1.99) 0.60–3.01 
 NP + GP Frugivorous 28 (1.61) 28 (1.61) 0 10 (0.58) 0–1.61 
 NP + GP Insectivorous 2 (0.09) 2 (0.09) 0 0 0–0.09 
 NP + GP Total 30 (0.75) 30 (0.75) 0 10 (0.25) 0–0.75 
Bundibugyo       
 GP Frugivorous 301 (17.34) 59 (3.40) 0 93 (5.36) 0–17.34 
 GP Insectivorous 58 (2.64) 8 (0.36) 5 (0.23) 13 (0.59) 0.23–2.64 
 GP Total 361 (8.98) 68 (1.69) 22 (0.55) 107 (2.66) 0.55–8.98 
 VP Frugivorous 9 (0.52) 7 (0.40) 12 (0.69) 37 (2.13) 0.40–2.14 
 VP Insectivorous 0 1 (0.05) 8 (0.36) 20 (0.91) 0–0.91 
 VP Total 9 (0.22) 8 (0.20) 20 (0.5) 57 (1.42) 0.20–1.42 
Reston       
 GP Frugivorous 17 (0.98) 28 (1.61) 26 (1.50) 61 (3.51) 0.98–3.51 
 GP Insectivorous 3 (0.14) 10 (0.45) 10 (0.45) 29 (1.32) 0.14–1.32 
 GP Total 20 (0.50) 38 (0.94) 36 (0.90) 90 (2.24) 0.50–2.24 
*VP refers to viral protein 40 of Ebola virus. Results are presented for frugivorous (n = 1,736), insectivorous (n = 2,199), and total (n = 4,022) bats. GP, 
glycoprotein; K, Kissoudougou strain; M, Mayinga strain; NP, nucleoprotein; VP, viral protein. 
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RT-PCR Screening for Zaire Ebola Virus RNA
We screened 665 samples from the DRC (n = 193), 
Cameroon (n = 399), and Guinea (n = 73) by RT-PCR 
for the presence of Zaire Ebola virus RNA. Of the 294 
samples originating from bats previously documented 
to carry Zaire Ebola virus RNA (6) (i.e., H. monstrosus 
[132 from Cameroon, 1 from the DRC], M. torquata [20 
from Cameroon, 25 from the DRC], and E. franqueti [116 
from Cameroon]), all were negative for Zaire Ebola virus 
RNA. Of the 371 samples from bat species E. helvum (58 
from Cameroon, 165 from the DRC, 3 from Guinea), L. 
angolensis (8 from Cameroon, 4 from Guinea), M. pu-
sillus (2 from the DRC, 1 from Guinea), R. aegyptiacus 
(45 from Cameroon, 40 from Guinea), E. gambianus (25 
from Guinea), and Mops sp. (20 from Cameroon), all were 
negative for Zaire Ebola virus RNA.
Discussion
To clarify the role of bats in Ebola virus ecology and iden-
tify where the virus circulates between outbreaks, we tested 
>4,000 bats, almost doubling the total number of samples 
tested in all previous studies in Africa (5–7,42). We provided 
data on bats from Cameroon, added to the existing data on 
bats from Guinea and the DRC, and substantially increased 
the data available on insectivorous bats. We tested samples 
with the same assay, enabling comparison across species and 
countries. We used different statistical methods to determine 
positive sample numbers and expressed the proportion of 
reactive samples as a range on the basis of the different cut-
off values proposed by those methods. As has been done in 
studies of human Zaire Ebola virus survivors (28,43), we de-
fined Zaire and Sudan Ebola virus positivity as the presence 
of antibodies to both nucleoprotein and glycoprotein. As 
such, we estimated that 2–37 (0.05%–0.92%) bats were se-
ropositive for Zaire Ebola virus and 0–30 (0%–0.75%) bats 
were seropositive for Sudan Ebola virus (Table 3). Among 
insectivorous bats, we observed Zaire and Sudan Ebola vi-
rus antibodies only in Mops sp. bats, an observation that has 
previously been observed (13). We provided information 
on insectivorous Miniopterus and Rhinolophus bats and ex-
tended knowledge on Mops and Hipposideros bats; all 1,200 
Hipposideros samples were seronegative. We confirmed the 
presence of Zaire Ebola virus antibodies in only 1 of 3 fru-
givorous species in which Zaire Ebola virus RNA has been 
reported, that is, in H. monstrosus but not E. franqueti or 
M. torquata bats (6). However, this result might have been 
influenced by sample size, test used, and interpretation crite-
ria. We confirmed antibodies in E. helvum bats and showed 
that Zaire Ebola virus antibodies are widespread among this 
species across Africa: Ghana and Zambia, and with our data, 
also Cameroon, Guinea, and the DRC (13,14,16). We con-
firmed antibodies in R. aegyptiacus bats from Cameroon and 
Guinea, in agreement with previous findings in these bats 
from the Congo and Gabon (13). For E. gambianus bats 
from Ghana, we also observed Zaire Ebola virus reactivity 
of samples from this species in Guinea (15). In contrast with 
a previous study, we observed Sudan Ebola virus antibodies 
(not Zaire Ebola virus antibodies) in M. pusillus bats (13). 
We also identified Zaire Ebola virus antibodies in L. ango-
lensis bats from Cameroon, although only when using less 
stringent cutoff calculations.
When combining data from previous Zaire Ebola vi-
rus seroprevalence studies in bats with data from our study, 
only 1 insectivorous bat species (Mops sp.) and 8 frugivo-
rous bat species (E. helvum, E. gambianus, E. franqueti, H. 
monstrosus, L. angolensis, M. pusillus, M. torquata, R. ae-
gyptiacus) exhibited Zaire Ebola virus antibodies (13–16). 
As seen in bat samples from Zambia, we observed in this 
study Sudan Ebola virus antibodies in E. helvum bats from 
Guinea, Cameroon, and the DRC, suggesting that Zaire and 
Sudan Ebola viruses co-circulate and could be widespread 
among this species. However, only 1 other study has tested 
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Figure 2. Bat blood samples 
reactive to Ebola virus antigens, 
by statistical method used 
to determine cutoff, Guinea, 
Cameroon, and the Democratic 
Republic of the Congo, 2015–2017. 
Samples from frugivorous bats (n 
= 1,736) and insectivorous bats (n 
= 2,199) were tested by Luminex 
assay with GP, NP, and VP of the 
Zaire and Sudan lineages; GP and 
VP of the Bundibugyo lineage; 
and GP of the Reston lineage. GP, 
glycoprotein; K, Kissoudougou 
strain; M, Mayinga strain; NP, 
nucleoprotein; VP, viral protein 40.
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for Ebola viruses other than Zaire Ebola virus in E. helvum 
bats (16). In our study, we also observed Sudan Ebola virus 
antibodies in Mops sp., H. monstrosus, and R. aegyptiacus 
bats in Cameroon. Almost all samples were positive for ei-
ther Zaire or Sudan Ebola virus but not for both.
Despite the presence of Ebola virus antibodies, the 
role of bats as reservoir species remains unclear because 
viral RNA detection is rare. In only 1 study Zaire Ebola vi-
rus RNA was amplified in a few bats (6). Thus, antibodies 
might reflect previous acute infection with viral clear-
ance. Unlike inoculations with Marburg virus (44–46), 
experimental inoculation of R. aegyptiacus bats with 
Zaire Ebola virus leads to antibody development but in-
frequent or absent detection of viral RNA or shedding 
(44,47). R. aegyptiacus bats are therefore able to clear 
Zaire Ebola virus after a short infectious period with-
out viral shedding and with little or no transmission. No 
antibodies or viral RNA were detected in noninoculated 
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Table 4. Blood samples from bats reactive with both nucleoprotein and glycoprotein of Zaire or Sudan Ebola virus, by statistical 
method used to determine cutoff, Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017 
Bat family, genus 
No. 
tested 
Ebola 
virus 
species 
Statistical method 
Mean + 4SD  Change-point  Binomial  Exponential 
No. % (95% CI) No. % (95% CI) No. % (95% CI) No. % (95% CI) 
Hipposideridae              
 Hipposideros sp. 1,282 Zaire 0  0 (0–0.3)  0 0 (0–0.3)  0 0 (0–0.3)  0 0 (0–0.3) 
 1,282 Sudan 0  0 (0–0.3)  0 0 (0–0.3)  0 0 (0–0.3)  0 0 (0–0.3) 
Miniopteridae              
 Miniopterus sp. 232 Zaire 0  0 (0–1.6)  0  0 (0–1.6)  0  0 (0–1.6)  0  0 (0–1.6) 
 232 Sudan 0  0 (0–1.6)  0  0 (0–1.6)  0  0 (0–1.6)  0  0 (0–1.6) 
Molossidae              
 Chaerephon sp. 44 Zaire 0  0 (0–8.0)  0  0 (0–8.0)  0  0 (0–8.0)  0  0 (0–8.0) 
 44 Sudan 0  0 (0–8.0)  0  0 (0–8.0)  0  0 (0–8.0)  0  0 (0–8.0) 
 Mops sp. 494 Zaire 6  1.2 (0.6–2.6)  6  1.2 (0.6–2.6)  1 0.2 (0.03–1.1)  1  0.2 (0.03–1.1) 
 494 Sudan 2  0.4 (0.1–1.5)  2  0.4 (0.1–1.5)  0  0 (0–0.8)  0  0 (0–0.8) 
Nycteridae              
 Nycteris sp 22 Zaire 0 0 (0–14.9)  0 0 (0–14.9)  0 0 (0–14.9)  0 0 (0–14.9) 
 22 Sudan 0 0 (0–14.9)  0 0 (0–14.9)  0 0 (0–14.9)  0 0 (0–14.9) 
Rhinolophidae              
 Rhinolophus sp. 86 Zaire 0  0 (0–4.3)  0  0 (0–4.3)  0  0 (0–4.3)  0  0 (0–4.3) 
 86 Sudan 0 0 (0–4.3)  0  0 (0–4.3)  0  0 (0–4.3)  0  0 (0–4.3) 
Vespertilionidae              
 Glauconycteris sp.* 3 Zaire 0   0   0   0  
 3 Sudan 0   0   0   0  
 Kerivoula sp.* 1 Zaire 0   0   0   0  
 1 Sudan 0   0   0   0  
 Myotis bocagii* 3 Zaire 0   0   0   0  
 3 Sudan 0   0   0   0  
 Neoromicia sp.* 5 Zaire 0   0   0   0  
 5 Sudan 0   0   0   0  
 Scotophilus sp. 22 Zaire 0  0 (0–14.9)  0  0 (0–14.9)  0  0 (0–14.9)  0  0 (0–14.9) 
 22 Sudan 0  0 (0–14.9)  0  0 (0–14.9)  0  0 (0–14.9)  0  0 (0–14.9) 
Pteropodidae              
 Eidolon helvum 480 Zaire 16  3.3 (2.1–5.4)  16  3.3 (2.1–5.4)  1  0.2 (0–1.2)  4  0.8 (0.3–2.1) 
 480 Sudan 14  2.9 (1.7–4.8)  14  2.9 (1.7–4.8)  0  0 (0–0.8)  5  1.0 (0.4–2.4) 
 Epomophorus sp. 207 Zaire 1  0.5 (0.08–2.7)  1  0.5 (0.08–2.7)  0  0 (0–1.4)  0  0 (0–1.8) 
 207 Sudan 0  0 (0–1.8)  0  0 (0–1.8)  0  0 (0–1.8)  0  0 (0–1.8) 
 Epomops sp. 280 Zaire 0  0 (0–1.4)  0  0 (0–1.4)  0  0 (0–1.4)  0  0 (0–1.4) 
 280 Sudan 0  0 (0–1.4)  0  0 (0–1.4)  0  0 (0–1.4)  0  0 (0–1.4) 
 Hypsignathus  
 monstrosus 
185 Zaire 3  1.6 (0.6–4.7)  3  1.6 (0.6–4.7)  0  0 (0–2.0)  1  0.5 (0.05–3.0) 
185 Sudan 8  4.3 (2.2–8.3)  8  4.3 (2.2–8.3)  3  1.6 (0.6–4.7)  2  1.1(0.3–3.9) 
 Lissonycteris  
 angolensis 
84 Zaire 2  2.4 (0.7–8.3)  2  2.4 (0.7–8.3)  0  0 (0–4.4)  0  0 (0–4.4) 
84 Sudan 0  0 (0–4.4)  0  0 (0–4.4)  0  0 (0–4.4)  0  0 (0–4.4) 
 Megaloglossus  
 woermanni 
20 Zaire 0  0 (0–16.1)  0  0 (0–16.1)  0  0 (0–16.1)  0  0 (0–16.1) 
20 Sudan 0  0 (0–16.1)  0  0 (0–16.1)  0  0 (0–16.1)  0  0 (0–16.1) 
 Micropteropus  
 pusillus 
64 Zaire 0  0 (0–5.7)  0  0 (0–5.7)  0  0 (0–5.7)  0  0 (0–5.7) 
64 Sudan 1  1.6 (0.3–8.3)  1  1.6 (0.3–8.3)  0  0 (0–5.7)  0  0 (0–5.7) 
 Myonycteris  
 torquata 
56 Zaire 0  0 (0–6.4)  0  0 (0–6.4)  0  0 (0–6.4)  0  0 (0–6.4) 
56 Sudan 0  0 (0–6.4)  0  0 (0–6.4)  0  0 (0–6.4)  0  0 (0–6.4) 
 Rousettus 
 aegyptiacus 
359 Zaire 9  2.5 (1.3–4.7)  9  2.5 (1.3–4.7)  0  0 (0–1.1)  2  0.6 (0.2–2.0) 
359 Sudan 5  1.4 (0.6–3.2)  5  1.4 (0.6–3.2)  0  0 (0–1.1)  3  0.8 (0.3–2.4) 
 Scotonycteris  
 zenkeri* 
1 Zaire 0   0   0   0  
1 Sudan 0   0   0   0  
*Percentages were not calculated because the number of samples collected was too low. 
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bats housed with experimentally Zaire Ebola virus– 
infected bats (44). Whether this low level of infectiousness 
also occurs for other bat species that carry Ebola virus an-
tibodies remains to be determined. Zaire Ebola virus was 
experimentally inoculated in other bat species (M. condylu-
rus, Chaerephon pumilus, and Epomophorus wahlbergi) 
in only 1 study; virus replication was seen in all species, 
and fecal shedding was seen in E. wahlbergi bats (48). R. 
aegyptiacus bats experimentally infected with Marburg 
virus were shown to develop antibodies that protect against 
reinfection (49). Long-term survival with Zaire Ebola vi-
rus antibodies has been reported with E. helvum bats from 
Ghana but without information on protection (14). Among 
insectivorous bats, the presence of Ebola virus antibodies 
in only Mops sp. is striking, suggesting higher exposure or 
susceptibility compared with other insectivorous bats.
In conclusion, we demonstrated higher rates of Eb-
ola virus antibodies in frugivorous than in insectivorous 
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Table 5. Zaire Ebola virus antibodies in insectivorous bats from our research, Guinea, Cameroon, and the DRC, 2015–2017, and other 
published studies* 
Family  Species Country 
Year of study 
(reference) Test 
No. 
tested 
No. (%) 
positive† 
Total, no. 
positive/tested (%)† 
Emballonuridae Coleura afra Cameroon 2015–2017‡ Luminex 5 0–0 (0–0) 0/14 (0) 
 Saccolaimus peli DRC 1979–1980 (26) IFA 9 0 (0)  
Hipposideridae Hipposideros sp. DRC 2015–2017‡ Luminex 157 0–0 (0–0) 0/1,395 (0) 
 Hipposideros sp. Cameroon 2015–2017‡ Luminex 837 0–0 (0–0)  
 Hipposideros sp. DRC 1979–1980 (26) IFA 69 0 (0)  
 Hipposideros sp. Guinea 2015–2017‡ Luminex 288 0–0 (0–0)  
 Hipposideros sp. Guinea 2014 (11) ELISA 44 0 (0)  
Miniopteridae Miniopterus sp. Guinea 2015–2017‡ Luminex 27 0–0 (0–0) 0/234 (0) 
 Miniopterus sp. DRC 2015–2017‡ Luminex 205 0–0 (0–0)  
 M. minor DRC 1995 (27) ELISA 2 0 (0)  
Molossidae Chaerephon sp. Guinea 2015–2017‡ Luminex 44 0–0 (0–0) 0/401 (0) 
 C. pumilus Guinea 2014 (11) ELISA 1 0 (0)  
 C. ansorgei DRC 1995 (27) ELISA 120 0 (0)  
 C. major DRC 1979–1980 (26) IFA 26 0 (0)  
 C. pumilus DRC 1995 (27) Elisa 210 0 (0)  
 Mops sp. Guinea 2015–2017‡ Luminex 230 0–0 (0–0) 4–9/705 (0.6–1.3) 
 Mops sp. Cameroon 2015–2017‡ Luminex 264 1–6 (0.4–2.3)  
 Mops sp. DRC 1979–1980 (26) IFA 158 0 (0)  
 Mops sp. DRC 1995 (27) ELISA 28 0 (0)  
 Mops condylurus Gabon 2003–2008 (13) ELISA 24 3 (12.5)  
 M. condylurus Guinea 2014 (11) ELISA 1 0 (0)  
 Myopterus whitleyi DRC 1995 (27) ELISA 2 0 (0)  
Nycteridae Nycteris sp. Guinea 2015–2017‡ Luminex 15 0–0 (0–0) 0/43 (0) 
 Nycteris sp. Guinea 2014 (11) ELISA 6 0 (0)  
 Nycteris sp. Cameroon 2015–2017‡ Luminex 7 0–0 (0–0)  
 Nycteris sp. DRC 1979–1980 (26) IFA 14 0 (0)  
 Nycteris hispida DRC 1995 (27) ELISA 1 0 (0)  
Rhinolophidae Rhinolophus sp. Guinea 2015–2017‡ Luminex 26 0–0 (0–0) 0/86 (0) 
 Rhinolophus sp. DRC 2015–2017‡ Luminex 6 0–0 (0–0)  
 Rhinolophus sp. Cameroon 2015–2017‡ Luminex 54 0–0 (0–0)  
Vespertilionidae Glauconycteris variegata Cameroon 2015–2017‡ Luminex 3 0–0 (0–0) 0/143 (0) 
 Chalinolobus sp. DRC 1979–1980 (26) IFA 15 0 (0)  
 Eptesicus sp. DRC 1979–1980 (26) IFA 22 0 (0)  
 Eptesicus tenuipinnis DRC 1995 (27) ELISA 1 0 (0)  
 Kerivoula sp. Guinea 2014 (11) ELISA 1 0 (0)  
 Kerivoula sp. Cameroon 2015–2017‡ Luminex 1 0–0 (0–0)  
 Myotis bocagii Cameroon 2015–2017‡ Luminex 3 0–0 (0–0)  
 M. bocagii DRC 1995 (27) ELISA 22 0 (0)  
 M. bocagii DRC 1979–1980 (26) IFA 17 0 (0)  
 Neoromicia sp. Cameroon 2015–2017‡ Luminex 5 0–0 (0–0)  
 Pipistrellus nanus DRC 1995 (27) ELISA 2 0 (0)  
 Scotophilus nux Cameroon 2015–2017‡ Luminex 6 0–0 (0–0)  
 Scotophilus leucogaster Guinea 2015–2017‡ Luminex 15 0–0 (0–0)  
 Scotophilus nigrita Guinea 2015–2017‡ Luminex 1 0–0 (0–0)  
 Scotophilus dinganii DRC 1995 (27) ELISA 19 0 (0)  
 Scotophilus sp. DRC 1979–1980 (26) IFA 10 0 (0)  
Total       4–9/3,023 (0.13–0.30) 
*DRC, the Democratic Republic of the Congo; IFA, immunofluorescence assay. 
†For data from cited studies, the number of positive samples reported in the original study is indicated. For our results, we show the range in the number 
of samples simultaneously reactive with glycoprotein and nucleoprotein of Zaire Ebola virus on the basis of 4 different statistical methods used to 
determine cutoff values. 
‡This study. 
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Table 6. Zaire Ebola virus antibodies in frugivorous (Pteropodidae family) bats from our research, Guinea, Cameroon, and the DRC, 
2015–2017, and published studies* 
Species Country 
Year of study 
(reference) Test 
No. 
tested 
No. (%) 
positive Total, no. positive/tested (%) 
Casinycteris ophiodon Guinea 2014 (11) ELISA 1 0 0/20 
Casinycteris argynnis Gabon, Congo 2003–2008 (13) ELISA 18 0  
C. argynnis DRC 1995 (27) ELISA 1 0  
Eidolon helvum† Guinea 2014 (11) ELISA 6 0 21–36/1,551 (1.4–2.3) 
 Guinea 2015–2017‡ Luminex 17 0–3 (0–17.6)  
 Ghana 2008 (14) IFA 262 1 (0.39)  
 Cameroon 2015–2017‡ Luminex 158 1–9 (0.6–5.7)  
 Gabon, Congo 2003–2008 (13) ELISA 49 0  
 DRC 1979–1980 (26) IFA 6 0  
 DRC 2015–2017‡ Luminex 305 0–4 (0–1.3)  
 Zambia 2006–2013 (16) ELISA 748 19 (2.55)  
Epomophorus gambianus Guinea 2015–2017‡ Luminex 191 0–1 (0–0.5) 4–5/244 (1.6–2.0) 
 Ghana 2007 (15) ELISA 37 4 (10.82)  
Epomophorus wahlbergi Cameroon 2015–2017‡ Luminex 16 0–0 (0–0)  
Epomops buettikoferi Guinea 2014 (11) ELISA 17 0 47/1,269 (3.7) 
 Guinea 2015–2017‡ Luminex 4 0–0 (0–0)  
Epomops franqueti Ghana 2007 (15) ELISA 27 3 (11.2)  
 Cameroon 2015–2017‡ Luminex 256 0–0 (0–0)  
 Gabon, Congo 2001–2005 (6) ELISA 117 8 (6.8)  
 Gabon, Congo 2003–2008 (13) ELISA 805 36 (4.5)  
 DRC 2015–2017‡ Luminex 20 0–0 (0–0)  
 DRC 1979–1980 (26) IFA 21 0  
 DRC 1995 (27) ELISA 2 0  
Hypsygnathus monstrosus Guinea 2015–2017‡ Luminex 8 0–0 (0–0) 15–18/347 (4.3–5.2) 
 Guinea 2014 (13) ELISA 1 0  
 Ghana 2008 (14) IFA 3 0  
 Ghana 2007 (15) ELISA 16 2 (12.5)  
 Cameroon 2015–2017‡ Luminex 176 0–3 (0–1.7)  
 Gabon, Congo 2001–2005 (6) ELISA 17 4 (23.5)  
 Gabon, Congo 2003–2008 (13) ELISA 125 9 (7.2)  
 DRC 2015–2017‡ Luminex 1 0–0 (0–0)  
Lissonycteris angolensis Guinea 2014 (11) ELISA 45 0 0–2/129 (0–1.6) 
 Guinea 2015–2017‡ Luminex 32 0–0 (0–0)  
 DRC 2015–2017‡ Luminex 22 0–0 (0–0)  
 Cameroon 2015–2017‡ Luminex 30 0–2 (0–6.7)  
Megaloglossus azagnyi Guinea 2014 (11) ELISA 3 0 0/110 
Megaloglossus woermanni Cameroon 2015–2017‡ Luminex 19 0–0 (0–0)  
 Gabon, Congo 2003–2008 (13) ELISA 49 0  
 DRC 2015–2017‡ Luminex 1 0–0 (0–0)  
 DRC 1995 (27) ELISA 38 0  
Micropteropus pusillus Guinea 2015–2017‡ Luminex 18 0–0 (0–0) 4/339 (1.2) 
 Cameroon 2015–2017‡ Luminex 2 0–0 (0–0)  
 Gabon, Congo 2003–2008 (13) ELISA 197 4 (2.04)  
 DRC 2015–2017‡ Luminex 44 0–0 (0–0)  
 DRC 1995 (27) ELISA 78 0  
Myonycteris leptodon Guinea 2014 (11) ELISA 21 0 23–27/708 (3.2–3.8) 
Myonycteris torquata Cameroon 2015–2017‡ Luminex 21 0–0 (0–0)  
 Gabon, Congo 2001–2005 (6) ELISA 58 4 (6.9)  
 Gabon, Congo 2003–2008 (13) ELISA 573 19 (3.32)  
 DRC 2015–2017‡ Luminex 35 0–0 (0–0)  
Nanonycteris veldkampii Guinea 2014 (11) ELISA 17 0 0/21 
 Ghana 2007 (15) ELISA 4 0  
Rousettus aegyptiacus Guinea 2015–2017‡ Luminex 228 0–1 (0–0.4) 24–33/666 (3.6–5.0) 
 Cameroon 2015–2017‡ Luminex 131 0–8 (0–6.1)  
 Gabon, Congo 2003–2008 (13) ELISA 307 24 (7.8)  
Scotonycteris zenkeri Cameroon 2015–2017‡ Luminex 1 0–0 (0–0) 0–0/1 (0–0) 
Total      138–172/5,405 (2.55–3.18) 
*DRC, the Democratic Republic of the Congo; IFA, immunofluorescence assay. 
†For cited studies, the number of positive samples reported in the original study is indicated. For our results, we show the range in the number of  
samples simultaneously reactive with glycoprotein and nucleoprotein of Zaire Ebola virus on the basis of 4 different statistical methods used to determine 
cutoff values. 
‡This study. 
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bats. The total number of frugivorous species shown to 
be Zaire Ebola virus seropositive has increased to 8, and 
1 insectivorous bat species (Mops sp.) was confirmed to 
be seropositive. Zaire and Sudan Ebola viruses circulate 
in different species across Africa, with potential co-cir-
culation of both viruses in some species. Although we 
have data on >8,000 bats from >40 species, this sample 
size is small, given the high numbers of bats that con-
stitute colonies. This study illustrates the complexity of 
tracking the animal reservoir of Ebola viruses, not only 
because sampling of wild bats without performing eu-
thanasia is difficult and time-consuming but also because 
of the absence of a reference standard for serologic tests. 
To clarify the significance of Ebola virus antibodies, 
documenting the extent to which viral RNA and shed-
ding can be detected in species with antibodies is crucial 
for predicting and controlling the risk for new outbreaks. 
Efforts must continue not only to sample bats but also 
other animals to elucidate where the virus circulates 
in wildlife.
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